AstraZeneca, Daiichi Sankyo in $6B oncology deal
Web Hosting

AstraZeneca PLC said Monday that it has entered into an oncology collaboration with Daiichi Sankyo Co. worth up to $6 billion that it said could redefine treatment standards in lung, breast and multi…
Read More